Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
23
pubmed:dateCreated
2005-6-8
pubmed:abstractText
Recent evidence suggests that amyloidogenic oligomers may be the toxic species in cell cultures. Thus, it is crucial to understand their structure and oligomerization mechanism in atomistic detail. By employing tens of fast central processing units and an advanced phase-space sampling algorithm, parallel-tempering molecular dynamics, we have explored the energy landscape of amyloidogenic peptide oligomerization in explicit water. A pentapeptide, DFNKF, derived from human calcitonin and its mutant, DFAKF, was simulated with a total simulation time of approximately 500 ns. The detailed oligomerization process of a DFNKF parallel beta-sheet formation at 300 K has been characterized. The assembly of a parallel beta-sheet from the amorphous state mainly occurs via a "bottleneck" channel where the interstrand Asn-Asn stacking is the major interaction. The interactions of Asn-Asn stacking include both backbone and side-chain hydrogen bonds. The Asn-Asn interactions work like "glue" by sticking the DFNKF strands together and assist the "on-pathway" oligomerization. The Asn-Asn stacking observed here is similar to the Asn ladder commonly found in globular beta-helix proteins. A control run shows that when Asn is mutated to Ala, the stability and population of the DFAKF parallel beta-sheet is decreased. Furthermore, our in vitro mutagenesis experiments show that the ability of DFAKF peptides to form amyloid fibrils is significantly reduced, in agreement with the simulations. Knowledge of the energy landscape of oligomerization may provide hints for rational drug design, preventing amyloid-associated diseases.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-10470028, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-10656810, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-10899428, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-11050225, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-11226247, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-11384401, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-11572942, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-11747907, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-11752441, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-11960014, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-12095997, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-12130773, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-12367525, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-12391326, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-12481027, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-12579582, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-12700355, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-12702875, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-12714741, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-12727509, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-12808142, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-1311922, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-14581616, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-14623983, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-14715898, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-14745805, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-15102455, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-15155909, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-15240453, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-15282319, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-15340923, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-15465917, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-15478463, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-15630094, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-15644216, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-15653506, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-3477791, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-8454614, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-8749853, http://linkedlifedata.com/resource/pubmed/commentcorrection/15923262-9094324
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
7
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8174-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Energy landscape of amyloidogenic peptide oligomerization by parallel-tempering molecular dynamics simulation: significant role of Asn ladder.
pubmed:affiliation
Basic Research Program, SAIC-Frederick, Inc., Laboratory of Experimental and Computational Biology, National Cancer Institute, Building 469, Room 145, Frederick, MD 21702, USA. tsaih@ncifcrf.gov
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural